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Purpose: Patients presenting with acutely decompensated heart failure (ADHF) and 
positive troponin were found to be a high-risk cohort. Measurement of cardiac 
troponins in this setting adds important prognostic information. The aim of this study is 
to determine the early evolution, associations, and correlations of high-sensitivity 
troponin T (hsTnT) in ADHF. 
Methods: Secondary analysis of a prospective study including 100 patients with ADHF. 
In that study patients were non-randomly assigned in a 1:1 ratio to spironolactone 100 
mg/day plus standard ADHF therapy or standard ADHF therapy alone. Data were 
collected in the first admission day (before spironolactone administration) and at day 3 
of hospitalization.
Results: Globally, high-sensitivity troponin T decreased from day 1 to day 3 (median 
[IQR], 0,033 [0,019 – 0,050] vs. 0,030 [0,018 – 0,051], p = 0,039). However, in the 
subgroup of patients who remained decompensated no significant differences in hsTnT 
from day 1 to day 3 were observed (median [IQR], from 0,046 [0,033 - 0,087] to 0,055 
[0,032 - 0,072], p = 0,955), whereas in successfully compensated patients a significant 
reduction in hsTnT levels was observed (median [IQR], from 0,032 [0,017 - 0,048] to 
0,028 [0,017 - 0,045], p = 0,025). High sensitivity troponin T decrease was correlated 
with NTproBNP reduction (NAC [95%CI], 0,267 [0,044 to 0,276], p = 0,007). Patients with 
hsTnT increase had lower NTproBNP decrease (median [IQR], -1187 [-2371 to 441] vs. -
411 [-1295 to 36], p = 0,002) and had longer length of stay (median [IQR], 8,0 [6 to 11] 
vs. [9,0 [7 to 12], p = 0,033).
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Conclusions: : Episodes of ADHF are associated with transient increases in the 
blood levels of hsTnT that are reduced with effective acute episode treatment. 
The decrease in hsTnT and NTproBNP are correlated which can translate 
ventricular wall stress relief with ADHF treatment.
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Figure: Differences in hsTnT Between Diuretic Responders and Non-Responders at Day 1 and Day 3
r = 0,267; p = 0,007
Figure: Correlation Between Δ Log hsTnT and Δ Log NTProBNP
